Thermo Fisher Scientific Inc ($TMO) Stock Forecast: Down 5.2% Today

What is Thermo Fisher Scientific Inc?

Thermo Fisher Scientific (TMO) is a leading company in the life sciences industry, providing a wide range of analytical instruments, reagents, consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics.

Why is Thermo Fisher Scientific Inc going down?

TMO stock is down 5.2% on Jan 29, 2026 14:41

• Thermo Fisher (TMO) experienced a bearish movement despite reporting better-than-expected Q4 CY2025 results, with revenue surpassing analyst estimates and strong performance in its Life Sciences Solutions segment.
• The stock might have faced downward pressure due to profit-taking by investors following the immediate stock increase post-earnings report.
• The overall market sentiment could have been influenced by broader market conditions or sector rotation, leading to the bearish movement in TMO's stock price today.
• It's possible that investors were expecting even stronger guidance or future outlook from the company, causing some disappointment and resulting in the bearish market movement.

TMO Price Chart

TMO Technical Analysis

TMO News

Danaher stock rating reiterated at Overweight by KeyBanc on bioprocess growth

KeyBanc has reiterated an Overweight rating on Danaher (NYSE:DHR) with a $310.00 price target, citing strong bioprocess growth and improving market conditions. The company's fourth-quarter 2025 results showed the fifth consecutive quarter of high-single-digit or better bioprocess growth, along with positive indicators from diagnostics and Life Science end markets. Despite a weaker dollar and conservative first-quarter 2026 guidance, KeyBanc remains confident in Danaher's potential for core growth and future M&A, supported by strong financial health and consistent dividend payments.

https://www.investing.com/news/analyst-ratings/danaher-stock-rating-reiterated-at-overweight-by-keybanc-on-bioprocess-growth-93CH-4473179

Thermo Fisher (NYSE:TMO) Posts Better-Than-Expected Sales In Q4 CY2025

Thermo Fisher (NYSE:TMO) reported better-than-expected Q4 CY2025 results, with revenue of $12.22 billion surpassing analyst estimates by 2.1% and non-GAAP EPS of $6.57 beating consensus by 1.9%. While the company's revenue growth has slowed over the past two years, organic revenue was flat, indicating core operations drove the results. Despite a slight miss on adjusted EBITDA and a flat operating margin year-over-year, the company's performance led to a immediate stock increase.

https://finviz.com/news/291375/thermo-fisher-nyse-tmo-posts-better-than-expected-sales-in-q4-cy2025

Thermo Fisher stock higher after Q4 beat (TMO:NYSE)

Thermo Fisher Scientific (TMO) shares rose in premarket trading after the company reported stronger-than-expected Q4 2025 results. The positive performance was primarily driven by its Life Sciences Solutions segment. The company posted adjusted earnings per share of $6.57.

https://seekingalpha.com/news/4544104-thermo-fisher-stock-higher-q4-beat

Thermo Fisher beats quarterly results estimates on demand for tools from pharma clients

Thermo Fisher Scientific exceeded Wall Street's expectations for fourth-quarter profit and revenue, driven by robust demand for its tools and services from pharmaceutical clients in drug development. This performance reflects improving conditions in the pharmaceutical market, which is helping life sciences firms counteract ongoing weakness in academic research funding. Rival company Danaher also reported better-than-expected results for the same quarter.

https://www.reuters.com/business/healthcare-pharmaceuticals/thermo-fisher-beats-quarterly-results-estimates-demand-tools-pharma-clients-2026-01-29/

Thermo Fisher: Q4 Earnings Snapshot

Thermo Fisher Scientific Inc. (TMO) reported strong fourth-quarter earnings, with net income totaling $1.96 billion, or $5.21 per share. Adjusted earnings of $6.57 per share surpassed Wall Street expectations, as did revenue of $12.22 billion. For the full year, the company achieved a profit of $6.7 billion on revenue of $44.56 billion.

https://www.kare11.com/article/syndication/associatedpress/thermo-fisher-q4-earnings-snapshot/616-453323ad-40c4-40a2-a70e-609138ba59e3

Trending Today

Hasbro Inc. ($HAS) Stock Forecast: Up 5.0% Today

Cardano ($ADA) Crypto Forecast: Up 5.6% Today

MicroVision Inc. ($MVIS) Stock Forecast: Down 5.8% Today

Western Digital Corporation ($WDC) Stock Forecast: Up 7.9% Today

GameStop Corp. ($GME) Stock Forecast: Up 5.1% Today

Intel Corporation ($INTC) Stock Forecast: Up 5.4% Today

Monolithic Power Systems Inc. ($MPWR) Stock Forecast: Up 5.1% Today

Natural Gas ($GAS) Commodity Forecast: Down 13.4% Today

Astrazeneca PLC ($AZN) Stock Forecast: Down 0.4% Today

Moderna Inc. ($MRNA) Stock Forecast: Up 5.3% Today

Thermo Fisher Scientific Inc Price History

01.07.2025 - TMO Stock was down 5.1%

• The decline in Thermo Fisher Scientific's stock today may be linked to the adoption of a bearish stance by influential investors, as reflected in options trading activities.
• While TMO has consistently outperformed the market in the long run, short-term market sentiment and investor behavior can impact daily fluctuations.
• Investors might be capitalizing on gains or adjusting their positions in response to prevailing market conditions or internal company developments, influencing the stock's downward trajectory today.
• It is crucial for investors to assess both TMO's long-term growth prospects and the short-term market dynamics to make well-informed investment choices.

29.00.2026 - TMO Stock was down 5.2%

• Thermo Fisher (TMO) experienced a bearish movement despite reporting better-than-expected Q4 CY2025 results, with revenue surpassing analyst estimates and strong performance in its Life Sciences Solutions segment.
• The stock might have faced downward pressure due to profit-taking by investors following the immediate stock increase post-earnings report.
• The overall market sentiment could have been influenced by broader market conditions or sector rotation, leading to the bearish movement in TMO's stock price today.
• It's possible that investors were expecting even stronger guidance or future outlook from the company, causing some disappointment and resulting in the bearish market movement.

30.08.2025 - TMO Stock was up 3.8%

• The positive market response to TMO's bond offering suggests investor confidence in the company's financial stability.
• The continued bullish interest from financial institutions and traders signals strong belief in Thermo Fisher Scientific's growth potential.
• Overall, TMO's bullish performance today could be linked to the successful bond offering and positive market sentiment.

02.00.2026 - TMO Stock was up 2.2%

• The global single-use bioprocessing products market is expected to witness substantial growth, with Thermo Fisher Scientific Inc. playing a significant role in the industry's advancement, contributing to the optimistic market trends.
• Noteworthy increases in stakes by Allspring Global Investments Holdings LLC and Ninety One UK Ltd in TMO reflect a growing confidence in the company's future, potentially influencing a rise in the stock's value.
• Despite recent significant insider sales, the company's impressive quarterly earnings report surpassing expectations, coupled with the initiation of a new stock buyback program and quarterly dividend declaration, have likely bolstered investor trust in TMO.
• The collective institutional interest and portfolio adjustments by different investment entities indicate a favorable outlook for TMO, aligning with the current bullish market movement.

18.11.2025 - TMO Stock was down 2.4%

• The decline in TMO stock may be linked to profit-taking by institutional investors actively trading the stock.
• Despite positive updates on strong quarterly earnings and a $5 billion share buyback program, concerns arose among investors due to insider selling by the CEO and COO, potentially contributing to the stock's downward trend.
• Weak performance by West Pharmaceutical Services (WST) in the healthcare sector could have also impacted investor sentiment towards TMO, as some may have shifted away from underperforming healthcare stocks.
• In sum, today's bearish movement in TMO stock seems influenced by profit-taking, insider selling concerns, and broader sector trends affecting investor outlook.

23.06.2025 - TMO Stock was up 11.9%

• Financial giants and deep-pocketed investors have shown a bullish sentiment towards Thermo Fisher Scientific, with a majority of traders leaning towards a positive outlook on the stock.
• The upcoming second-quarter earnings report, especially focusing on the Analytical Instruments segment, has generated optimism and interest among investors.
• The increased bullish options trading activity suggests that market players are anticipating positive growth and performance from Thermo Fisher Scientific in the near future.

23.06.2025 - TMO Stock was up 12.4%

• Q2 earnings and revenues of Thermo Fisher Scientific exceeded expectations, propelled by successful product launches and robust segment growth, resulting in a notable increase in the stock price.
• Notable bullish sentiment was observed in the options trends for TMO, with a majority of traders expressing optimism about the stock.
• Investors are placing emphasis on the growth prospects of Thermo Fisher's Analytical Instruments segment, foreseeing its positive impact on performance in the upcoming quarters.
• The optimistic outlook from major investors towards TMO, reflected through options activity, likely played a role in the stock's favorable market trajectory today.

22.06.2025 - TMO Stock was up 5.5%

• Thermo Fisher Scientific is set to report its Q2 earnings, with a focus on its Analytical Instruments segment, indicating potential positive performance in this area.
• The bullish approach adopted by deep-pocketed investors towards TMO, as reflected in the options market, could be driving the upward momentum in the stock price.
• The market seems optimistic about Thermo Fisher's growth prospects, especially with new technological launches in key segments, fueling investor confidence and contributing to the bullish movement in the stock today.

10.06.2025 - TMO Stock was up 4.6%

• Despite negative moves by financial institutions and stock downgrades by analysts, Thermo Fisher Scientific (TMO) saw a significant rise in stock price.
• Unusual options trading, displaying a mix of bullish and bearish trends, likely contributed to the stock's fluctuating price.
• Divergent opinions among traders and analysts may have caused market uncertainty, prompting increased buying activity and driving up the stock price.
• Investors possibly prioritized the company's strong fundamentals and future growth potential, overshadowing short-term bearish signals from analysts and options trades.

14.04.2025 - TMO Stock was down 5.0%

• The bearish movement in Thermo Fisher Scientific's stock today may be linked to Senator Markwayne Mullin's substantial sale of up to $700K worth of TMO shares, causing concerns among investors about the company's future prospects.
• Investors could be responding to the news of the Senator's sale by selling off their Thermo Fisher Scientific positions, putting downward pressure on the stock price.
• Despite the current bearish movement, Thermo Fisher Scientific's strong long-term fundamentals could offer a chance for investors to benefit from the stock price decline.

10.05.2025 - TMO Stock was up 3.3%

• The recent increase in TMO's stock price may be linked to the following factors:
• Investors' positive response to the 1.27% rise in TMO's price during the current market session, despite the recent downward trend.
• Possible renewed market optimism regarding TMO's future growth opportunities or potential positive developments within the company.
• The overall favorable market or sector sentiment may have buoyed TMO and other stocks, contributing to today's bullish movement.

01.09.2025 - TMO Stock was up 9.2%

• The stock of Thermo Fisher Scientific showed a strong upward trend today, likely influenced by a noteworthy Power Inflow alert, reflecting optimistic sentiment from institutional and retail investors.
• The company's decision to initiate a four-part bond offering in anticipation of a potential government shutdown might have also played a part in the positive trend, demonstrating proactive financial preparation and stability.
• The optimistic actions of financial institutions and the prevailing bullish sentiment among traders regarding TMO all contributed to the favorable momentum, underscoring confidence in the company's future prospects.